Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

The WTX tumor suppressor enhances p53 acetylation by CBP/p300.

Kim WJ, Rivera MN, Coffman EJ, Haber DA.

Mol Cell. 2012 Mar 9;45(5):587-97. doi: 10.1016/j.molcel.2011.12.025. Epub 2012 Jan 26.

2.

BIM expression in treatment-naive cancers predicts responsiveness to kinase inhibitors.

Faber AC, Corcoran RB, Ebi H, Sequist LV, Waltman BA, Chung E, Incio J, Digumarthy SR, Pollack SF, Song Y, Muzikansky A, Lifshits E, Roberge S, Coffman EJ, Benes CH, Gómez HL, Baselga J, Arteaga CL, Rivera MN, Dias-Santagata D, Jain RK, Engelman JA.

Cancer Discov. 2011 Sep;1(4):352-65. doi: 10.1158/2159-8290.CD-11-0106. Epub 2011 Jul 22.

3.

The WTX tumor suppressor regulates mesenchymal progenitor cell fate specification.

Moisan A, Rivera MN, Lotinun S, Akhavanfard S, Coffman EJ, Cook EB, Stoykova S, Mukherjee S, Schoonmaker JA, Burger A, Kim WJ, Kronenberg HM, Baron R, Haber DA, Bardeesy N.

Dev Cell. 2011 May 17;20(5):583-596. doi: 10.1016/j.devcel.2011.03.013. Erratum in: Dev Cell. 2012 May 15;22(5):1109-17.

4.

Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers.

Ting DT, Lipson D, Paul S, Brannigan BW, Akhavanfard S, Coffman EJ, Contino G, Deshpande V, Iafrate AJ, Letovsky S, Rivera MN, Bardeesy N, Maheswaran S, Haber DA.

Science. 2011 Feb 4;331(6017):593-6. doi: 10.1126/science.1200801. Epub 2011 Jan 13.

5.

Wilms tumor chromatin profiles highlight stem cell properties and a renal developmental network.

Aiden AP, Rivera MN, Rheinbay E, Ku M, Coffman EJ, Truong TT, Vargas SO, Lander ES, Haber DA, Bernstein BE.

Cell Stem Cell. 2010 Jun 4;6(6):591-602. doi: 10.1016/j.stem.2010.03.016.

6.

The tumor suppressor WTX shuttles to the nucleus and modulates WT1 activity.

Rivera MN, Kim WJ, Wells J, Stone A, Burger A, Coffman EJ, Zhang J, Haber DA.

Proc Natl Acad Sci U S A. 2009 May 19;106(20):8338-43. doi: 10.1073/pnas.0811349106. Epub 2009 May 4.

Supplemental Content

Loading ...
Support Center